PolyPharm Corp.

Service & Device to ensure patient compliance. PolyPharm's {MedManager} service links patients, physicians and payers with a patented hand-held pill dispensing device which alerts and instructs patients and also collects physiological data which can bedownloaded daily to medical personnel.

The behavior of patients between doctor visits has been one of the most unmanageable components of managed care. When patients don't comply with their treatment regimens, particularly in chronic diseases like diabetes, epilepsy, hypertension or asthma, the result can be a trip to the emergency room, or worse. Not only can patient non-compliance result in overuse of high-cost care (like emergency room services), it can lead to an overall higher use of health care services and contribute to the long-term progression of a patient's disease. Patients do want to comply, but it can be difficult to keep track of medications, diets and symptoms, especially for the chronically ill or the aged, who often suffer from a combination of illnesses.

Early attempts to influence patient compliance included paging devices to remind patients to take pills, or educational visits to the home by nurses. But the confluence of microelectronics and the...

More from R&D

More from Scrip

Merus Bispecific Impresses In Head And Neck Cancer

 

Updated Phase II results from petosemtamab have impressed ahead of ASCO, outshining Keytruda monotherapy and its bispecific rival from Bicara.

Zydus To Continue Mirabegron Sales, Looks To World-First Dual Shigella-Typhoid Vaccine

 
• By 

Zydus expects strong mirabegron sales in FY26 amid US litigation even as it builds a growth pillar in vaccines with a world-first, Gates Foundation-aided dual shigella-typhoid vaccine under development and others on the WHO prequalified list

Challenging Environment For Biopharma Is A Tailwind For Royalty Pharma

 

The royalty revenue stream acquirer has around 40 products in its portfolio and expects to generate roughly $3bn this year. Head of R&D and investments Marshall Urist talked about the investment strategy at the RBC Healthcare Conference.